Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.

Abstract:

:Factor IXa (FIXa) is a vitamin K-dependent coagulation serine protease which binds to factor VIIIa (FVIIIa) on negatively charged phospholipid vesicles (PCPS) to catalyse the activation of factor X (FX) to factor Xa (FXa) in the intrinsic pathway. Fluorescence resonance energy transfer (FRET) studies have indicated that the Gla-domain-dependent interaction of FIXa and FX with PCPS in the presence of FVIIIa positions the active-site of the protease at an appropriate height above the membrane surface to optimise the catalytic reaction. In this study, we investigated the contribution of the NH2-terminal EGF-domain (EGF1) of FIXa to the recognition specificity of intrinsic tenase by constructing an EGF1 deletion mutant of FIXa (FIXa-desEGF1) and characterising the properties of the mutant in kinetic, direct binding and FRET assays. The results of direct binding and kinetic studies demonstrated that the binding affinity of the mutant for interaction with FVIIIa on PCPS has been impaired greater than 10-fold and the catalytic efficiency of the mutant protease-FVIIIa-PCPS complex in the activation of FX has been decreased ~100-fold. By contrast, the mutant protease exhibited a normal activity toward FX in the absence of the protein cofactor. FRET measurements revealed that the distance of the active-site of the mutant FIXa relative to PCPS vesicles has been decreased 10 Å from 75 ± 2 Å for FIXa to 65 ± 2 Å for FIXa-desEGF1 independent of FVIIIa. These results suggest that the NH2-terminal EGF-domain of FIXa provides a binding-site for FVIIIa and plays an essential spacer function in the intrinsic tenase complex.

journal_name

Thromb Haemost

authors

Qureshi SH,Yang L,Rezaie AR

doi

10.1160/TH12-06-0436

subject

Has Abstract

pub_date

2012-12-01 00:00:00

pages

1154-64

issue

6

eissn

0340-6245

issn

2567-689X

pii

12-06-0436

journal_volume

108

pub_type

杂志文章
  • Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study.

    abstract::Low molecular weight heparin (LMWH) is used increasingly for prophylaxis and treatment of venous thromboembolism during pregnancy. However, the prophylactic dose for patients at moderate risk varies between centers, and the recommended LMWH dose for the non pregnant patient is frequently used in pregnant women. The ai...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH03-10-0618

    authors: Norris LA,Bonnar J,Smith MP,Steer PJ,Savidge G

    更新日期:2004-10-01 00:00:00

  • Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery.

    abstract::Subcutaneous heparin is the treatment of choice for women requiring anticoagulant therapy during pregnancy. However, heparin therapy presents a management problem at delivery because of its potential to cause a persistent anticoagulant effect and thus increase the risk of bleeding. In order to avoid therapeutic compli...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Anderson DR,Ginsberg JS,Burrows R,Brill-Edwards P

    更新日期:1991-03-04 00:00:00

  • A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.

    abstract:BACKGROUND:Recombinant hirudin, a pure, specific antithrombin could be more effective than heparin in the treatment of deep vein thrombosis, but its short half-life requires constant intravenous infusion, whereas subcutaneous administration of recombinant hirudin can ensure stable and prolonged plasma levels. The aim o...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章

    doi:

    authors: Schiele F,Vuillemenot A,Kramarz P,Kieffer Y,Soria J,Soria C,Camez A,Mirshahi MC,Bassand JP

    更新日期:1994-05-01 00:00:00

  • Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.

    abstract::The efficacy and safety of dabigatran for treatment of venous thromboembolism (VTE) were demonstrated in two trials. It is unclear if the results pertain to patients with cancer and VTE. Data from two randomised trials comparing dabigatran and warfarin for acute VTE were pooled. Primary efficacy outcome was symptomati...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH14-11-0977

    authors: Schulman S,Goldhaber SZ,Kearon C,Kakkar AK,Schellong S,Eriksson H,Hantel S,Feuring M,Kreuzer J

    更新日期:2015-07-01 00:00:00

  • Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy.

    abstract::We investigated changes in both thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels and its functional effect on in vitro fibrinolysis in normal pregnancy. 152 pregnant women and 31 women in the immediate postpartum period were studied, with pregnancy divided into 6 windows at 4 weekly intervals. As TAFI...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-06-0387

    authors: Mousa HA,Downey C,Alfirevic Z,Toh CH

    更新日期:2004-11-01 00:00:00

  • von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.

    abstract:BACKGROUND:Elevated von Willebrand factor (vWF) is a risk factor in the development of acute myocardial infarction. The importance of vWF and factor VII:C in the pathogenesis of cerebrovascular disease (CVD) is poorly defined. METHODS AND RESULTS:We studied 208 cases of stroke whose pathological type was defined by cr...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Catto AJ,Carter AM,Barrett JH,Bamford J,Rice PJ,Grant PJ

    更新日期:1997-06-01 00:00:00

  • The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.

    abstract::The contribution of the various components of the contact system in the generation of factor XIIa (FXIIa) and of kallikrein (KRN) on an electronegative surface and the release of the generated enzymes to the bulk phase was examined in mixtures of normal human plasma and plasmas congenitally deficient in these componen...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Mitropoulos KA

    更新日期:1999-09-01 00:00:00

  • The effects of metal ions on esterase activities of urokinase.

    abstract::The esterase activity of highly purified human urokinase on Nalpha-acetylglycl-L-lysine methyl ester is strongly inhibited by 1 X 10(-5) to 1 X 10(-2)M Cu++, Hg++, Ni++, Co++, Fe+++, and Mn++ solutions, whereas Na+, K+, Ca++, and Mg++ are weakly effective. This inhibition is parallel with the inhibition of activation ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Sumi H,Takada Y,Takada A

    更新日期:1978-02-28 00:00:00

  • The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms.

    abstract::Although, the main physiological role of monocytes is attributed to innate immunity (that is, phagocytosis) and the development of tissue macrophages and dendritic cells, the pathophysiological role of these goes far behind these (simplistic) limits. Indeed, monocytes constitute a major source of blood tissue factor, ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH09-01-0023

    authors: Shantsila E,Lip GY

    更新日期:2009-11-01 00:00:00

  • Quantification of Platelet Contractile Movements during Thrombus Formation.

    abstract::Imaging methods based on time-lapse microscopy are important tools for studying the dynamic events that shape thrombus formation upon vascular injury. However, there is a lack of methods to translate the vast amount of visual data generated in such experiments into quantitative variables describing platelet movements ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1055/s-0038-1668151

    authors: Tunströmer K,Faxälv L,Boknäs N,Lindahl TL

    更新日期:2018-09-01 00:00:00

  • Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin.

    abstract::The prophylactic treatment of haemophilia B and the management of haemophilia A or B with inhibitors demand frequent administrations of coagulation factors due to the suboptimal half-lives of the products commercially available and currently in use, e.g. recombinant factor IX (rFIX) and recombinant factor VIIa (rFVIIa...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH13-03-0213

    authors: Metzner HJ,Pipe SW,Weimer T,Schulte S

    更新日期:2013-11-01 00:00:00

  • Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.

    abstract::Dabigatran is an oral, reversible thrombin inhibitor that has shown promising results in large clinical trials. Laboratory monitoring is not needed but the effects on common coagulation assays are incompletely known. Dabigatran was added to plasma from healthy subjects in the concentration range 0-1,000 μg/l and analy...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH10-06-0342

    authors: Lindahl TL,Baghaei F,Blixter IF,Gustafsson KM,Stigendal L,Sten-Linder M,Strandberg K,Hillarp A,Expert Group on Coagulation of the External Quality Assurance in Laboratory Medicine in Sweden.

    更新日期:2011-02-01 00:00:00

  • Inflammatory profile of oxidized phospholipids.

    abstract::Lipid oxidation products and in particular oxidized phospholipids (OxPL) are increasingly recognized as inducers of chronic inflammation characteristic of atherosclerosis. OxPL stimulate production of chemokines and adhesion of monocytes to endothelial cells. However, accumulating data suggest that, in addition to the...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Bochkov VN

    更新日期:2007-03-01 00:00:00

  • Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.

    abstract::Tissue-type plasminogen activator (t-PA) is a fibrin-specific agent which is used to treat acute myocardial infarction. Pharmacokinetically, t-PA is characterized by a rapid clearance from the circulation. In a previous study, we constructed variant forms of t-PA with genetic modifications at the fibronectin finger-li...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Yahara H,Matsumoto K,Maruyama H,Nagaoka T,Ikenaka Y,Yajima K,Fukao H,Ueshima S,Matsuo O

    更新日期:1994-12-01 00:00:00

  • ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.

    abstract::Among the nine ellagitannins, rugosin E was the most potent platelet aggregating agent with an EC50 of 1.5 +/- 0.1 microM in rabbit platelets and 3.2 +/- 0.1 microM in human platelets. The aggregations caused by rugosin E and ADP were inhibited by EGTA, PGE1, mepacrine, sodium nitroprusside and neomycin, but not by in...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Teng CM,Kang YF,Chang YL,Ko FN,Yang SC,Hsu FL

    更新日期:1997-03-01 00:00:00

  • Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.

    abstract::It was the objective of this study to determine whether reduced cleavage of von Willebrand factor (VWF) multimers following aortic valve replacement (AVR) is a consequence of reduced shear stress or postoperative changes in VWF cleavage protease (ADAMTS-13) activity. Aortic stenosis (AS) may be complicated by acquired...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH11-12-0803

    authors: Bander J,Elmariah S,Aledort LM,Dlott J,Stelzer P,Halperin JL,Kini AS,Sharma SK

    更新日期:2012-07-01 00:00:00

  • Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines.

    abstract::Induction of procoagulant factors in malignant cells is considered to be the major cause of coagulation disorders in cancer. Thrombomodulin (TM), a negative regulator of coagulation was also found to be expressed in cancer cells. We report here evidence for another anticoagulant, the endothelial cell protein C recepto...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Tsuneyoshi N,Fukudome K,Horiguchi S,Ye X,Matsuzaki M,Toi M,Suzuki K,Kimoto M

    更新日期:2001-02-01 00:00:00

  • Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood.

    abstract::Previous studies have reported that the platelets of healthy term neonates have either diminished or normal reactivity compared to the platelets of adults. To circumvent the methodologic problems of previous studies, we used a whole blood flow cytometric method to study neonatal platelet reactivity to thrombin, a comb...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Rajasekhar D,Kestin AS,Bednarek FJ,Ellis PA,Barnard MR,Michelson AD

    更新日期:1994-12-01 00:00:00

  • Evidence from site-directed mutagenesis that the cytoplasmic domain of the beta3 subunit influences the conformational state of the alphaVbeta3 integrin ectodomain.

    abstract::In order to explore the mechanisms leading to conformational changes of the vitronectin receptor alphavbeta3 following ligand or divalent cation binding, we have investigated the expression of epitopes known as ligand-induced binding sites (LIBS) on beta3 cytoplasmic tail mutants expressed in CHO cells. Truncation of ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Schaffner-Reckinger E,Brons NH,Kieffer N

    更新日期:2001-04-01 00:00:00

  • Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.

    abstract::Antiphospholipid-protein antibodies (APA) include lupus-type anticoagulant (LA) and antibodies recognizing complexes of anionic phospholipids (e.g. cardiolipin) and proteins (e.g. prothrombin and beta2-glycoprotein I). The presence of APA is associated with an increased risk of both arterial and venous thrombosis. How...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Musiał J,Swadźba J,Jankowski M,Grzywacz M,Bazan-Socha S,Szczeklik A

    更新日期:1997-10-01 00:00:00

  • Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.

    abstract::The clinical benefits of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) have been shown in many trials. However, the mode of action of heparin has not been fully elucidated. Thus, we wanted to study the effects of UFH and LMWH in vivo by measuring coagulation activation markers in blood obtained ...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Eichinger S,Wolz M,Nieszpaur-Los M,Schneider B,Lechner K,Eichler HG,Kyrle PA

    更新日期:1994-12-01 00:00:00

  • Regulation of the tissue factor gene.

    abstract::Tissue factor is a cellular receptor that initiates blood coagulation. The TF gene is constitutively expressed in some extravascular cell types and is inducibly expressed in several vascular cell types, including monocytes, vascular endothelial cells and vascular smooth muscle cells. Functional studies indicate that S...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Mackman N

    更新日期:1997-07-01 00:00:00

  • Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.

    abstract::The interdependence of the predictive accuracy of serum osteoprotegerin (OPG) and von Willebrand factor (vWF) levels for long-term cardiovascular outcomes has not been investigated so far. This was a prospective observational cohort study in 361 patients with coronary artery disease undergoing percutaneous coronary in...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH17-02-0087

    authors: Siller-Matula J,Lang IM,Schoergenhofer C,Roest M,Jilma B

    更新日期:2017-08-30 00:00:00

  • Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets.

    abstract::Plasminogen activator inhibitor type-1 (PAI-1) is a physiologic modulator of the fibrinolytic system. We have shown previously that PAI-1 biosynthesis in cultured cells depends on several factors in serum. Because platelets are richly endowed with specific growth factors and because the release reaction is an integral...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Hopkins WE,Westerhausen DR,Fujii S,Billadello JJ,Sobel BE

    更新日期:1991-08-01 00:00:00

  • Risk of venous thromboembolism in patients with splenic injury and splenectomy. A nationwide cohort study.

    abstract::The spleen is a crucial organ in humans. However, little is known about the association of venous thromboembolism (VTE) with splenic injury and splenectomy in trauma patients. The aim of this study was to determine the subsequent risk of VTE following splenic injury and splenectomy. A nationwide retrospective cohort s...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH15-05-0381

    authors: Lin JN,Chen HJ,Lin MC,Lai CH,Lin HH,Yang CH,Kao CH

    更新日期:2016-01-01 00:00:00

  • Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.

    abstract::Circulating endotoxin is elevated in sepsis and plays a role in endothelial dysfunction whereas antithrombin is decreased by virtue of its consumption during complex formation with clotting factors and by proteolytic degradation by granulocyte elastase. Dysfunction of endothelium results in enhanced leukocyte rolling ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH03-03-0184

    authors: Kaneider NC,Förster E,Mosheimer B,Sturn DH,Wiedermann CJ

    更新日期:2003-12-01 00:00:00

  • The effects of standard and low molecular weight heparin on bone nodule formation in vitro.

    abstract::Previously, we demonstrated in a rat model of heparin-induced osteoporosis that low molecular weight heparin (LMWH) produces less bone loss than unfractionated heparin, and that only heparin increases osteoclast number and activity. In contrast, both heparin and LMWH were found to decrease osteoblast function to a sim...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Bhandari M,Hirsh J,Weitz JI,Young E,Venner TJ,Shaughnessy SG

    更新日期:1998-09-01 00:00:00

  • The fibrinolytic potential of the normal primate following the generation of thrombin in vivo.

    abstract::Parameters of the fibrinolytic system were studied in a primate model where the generation of thrombin was promoted in vivo. The procoagulant stimulus used was a combination of human factor Xa in combination with phosphatidylcholine/phosphatidylserine lipid vesicles (PCPS) as the source of coagulant active phospholipi...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Giles AR,Nesheim ME,Herring SW,Hoogendoorn H,Stump DC,Heldebrant CM

    更新日期:1990-06-28 00:00:00

  • Lipoprotein(a), plasmin modulation, and atherogenesis.

    abstract::Lipoprotein(a) [Lp(a)] is an atherogenic lipoprotein however the mechanisms by which Lp(a) promote the atherosclerotic process are not clear. The apolipoprotein(a) portion of Lp(a) shares partial homology with plasminogen, a finding that has stimulated numerous studies. Lp(a) binds to fibrin and the affinity between f...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Harpel PC,Hermann A,Zhang X,Ostfeld I,Borth W

    更新日期:1995-07-01 00:00:00

  • Maternal and fetal platelet responses and adrenoceptor binding characteristics.

    abstract::Paired blood samples were obtained from mothers (venous) and babies (cord venous blood) at the time of delivery by caesarean section under epidural anaesthetic. Fetal platelets failed to aggregate in response to adrenaline in vitro although adrenaline could potentiate the threshold response to adenosine diphosphate (1...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Jones CR,McCabe R,Hamilton CA,Reid JL

    更新日期:1985-02-18 00:00:00